| 000 | 01851 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518093225.0 | ||
| 264 | 0 | _c20210823 | |
| 008 | 202108s 0 0 eng d | ||
| 022 | _a1557-7422 | ||
| 024 | 7 |
_a10.1089/hum.2020.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKwon, Hyung-Joo | |
| 245 | 0 | 0 |
_aAdeno-Associated Virus D-Sequence-Mediated Suppression of Expression of a Human Major Histocompatibility Class II Gene: Implications in the Development of Adeno-Associated Virus Vectors for Modulating Humoral Immune Response. _h[electronic resource] |
| 260 |
_bHuman gene therapy _c05 2020 |
||
| 300 |
_a565-574 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDNA, Viral |
| 650 | 0 | 4 |
_aDependovirus _xgenetics |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenes, MHC Class II |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 |
_aHLA Antigens _xgenetics |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class II _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Humoral |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aRegulatory Factor X1 _xgenetics |
| 650 | 0 | 4 | _aSequence Homology |
| 650 | 0 | 4 | _aTerminal Repeat Sequences |
| 700 | 1 | _aQing, Keyun | |
| 700 | 1 | _aPonnazhagan, Selvarangan | |
| 700 | 1 | _aWang, Xu-Shan | |
| 700 | 1 | _aMarkusic, David M | |
| 700 | 1 | _aGupte, Siddhant | |
| 700 | 1 | _aBoye, Shannon E | |
| 700 | 1 | _aSrivastava, Arun | |
| 773 | 0 |
_tHuman gene therapy _gvol. 31 _gno. 9-10 _gp. 565-574 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/hum.2020.018 _zAvailable from publisher's website |
| 999 |
_c30788180 _d30788180 |
||